REVA Medical, Inc. ("REVA" or the "Company") is a medical device company that has developed a proprietary bioresorbable scaffold, as an alternative to metal stents, to treat coronary artery disease. Scaffolds provide restoration of blood flow, support the artery through the healing process, then disappear (or “resorb”) from the body over a period of time. This resorption allows the return of natural movement and function of the artery, a result not attainable with permanent metal stents...more »
Recent Media Covering
Sign up to receive the latest financial news and events by email.